These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4628191)

  • 1. [An experimental study on the antituberculous activity of tuberactiomycin-N].
    Toyoara M
    Kekkaku; 1972 Jun; 47(6):181-7. PubMed ID: 4628191
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 3. Virulence attenuation and other biological modifications in multiple drug resistant tubercle mycobacteria.
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P; Serafini NA; Termine A; Zubiani M
    Boll Ist Sieroter Milan; 1971; 50(4):353-61. PubMed ID: 5005885
    [No Abstract]   [Full Text] [Related]  

  • 4. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antituberculous activities of the tuberactinomycins in vitro and in experimental animals].
    Koseki Y; Okamoto S; Muroashi T
    Kekkaku; 1973 May; 48(5):189-96. PubMed ID: 4200134
    [No Abstract]   [Full Text] [Related]  

  • 6. Study on the antituberculous activity of tuberactinomycin, a new antimicrobial drug.
    Toyohara M; Nagata A; Hayano K; Abe J
    Am Rev Respir Dis; 1969 Aug; 100(2):228-30. PubMed ID: 4308717
    [No Abstract]   [Full Text] [Related]  

  • 7. [The experimental studies on antituberculous activity of lividomycin].
    Yamamoto K; Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 May; 47(5):135-8. PubMed ID: 4339540
    [No Abstract]   [Full Text] [Related]  

  • 8. [The virulence of resistance strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. II. Experimental therapeutic effect on guinea pigs infected by resistant strains of Mycobacterium tuberculosis].
    Yan BS
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):206-8. PubMed ID: 6816558
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study on the antituberculous activity of Tuberactin, a new antibiotic].
    Toyohara M
    Kekkaku; 1968 Jul; 43(7):245-8. PubMed ID: 5727835
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of drug-resistant mutants of the H37 Rv tubercular strain in experimental tuberculosis of the guinea pig].
    Aliperta A; Ninni A
    Arch Monaldi; 1972; 27(3):72-9. PubMed ID: 4219271
    [No Abstract]   [Full Text] [Related]  

  • 11. [Morphological aspects of the infection and re-infection with M.t. (Mycobacterium tuberculosis) resistant to chemo-antibiotics].
    Stroniello G
    Arch Monaldi; 1972; 27(3):284-9. PubMed ID: 4219269
    [No Abstract]   [Full Text] [Related]  

  • 12. [Discrepancy between drug resistance of mycobacterium tuberculosis determined in vitro and in vivo].
    Belogurova VP; Gorislavets II; Ivanitskaia NN
    Probl Tuberk; 1971; 49(6):76-80. PubMed ID: 5000746
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on antituberculous activity of lividomycin in vitro].
    Horai Z; Shimizu K; Yamamoto K; Fujisawa Y; Yamashita K
    Kekkaku; 1971 Oct; 46(10):401-4. PubMed ID: 5004573
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug resistance of Mycobacterium (including clinical studies)].
    Fukuhara T
    Kekkaku; 1976 May; 51(5):158-60. PubMed ID: 819705
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comments on the current state of experimental chemotherapy of tuberculosis].
    Urbancík R; Markovic J
    Z Tuberk Erkr Thoraxorg; 1967; 126(3):169-73. PubMed ID: 4971152
    [No Abstract]   [Full Text] [Related]  

  • 16. [The virulence of drug-resistant Mycobacterium tuberculosis in animals and the therapeutic effect and biochemical changes of the drugs].
    Zhao T
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Apr; 7(2):76-7. PubMed ID: 6435977
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study on tuberactinomycin, a new antibiotic].
    Osato T; Toyoara M
    Kekkaku; 1971 May; 46(3):59-63. PubMed ID: 4324041
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preclinical evaluation of alboverticillin, triculamine, and o-carbamyl-d-serine as a new antituberculous antibiotic].
    Kanai K; Koseki Y; Nakamura R; Okamoto S; Murohashi T
    Kekkaku; 1967 Jan; 42(1):37-42. PubMed ID: 6036570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance to antituberculosis drug in France; data provided by the Azay-Mycobacteria network and the National Reference Center on Mycobacteria].
    Robert J; Veziris N;
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S68-70. PubMed ID: 18598875
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.